40
D. Gong et al. / Applied Catalysis A: General 464–465 (2013) 35–42
yield). The same procedure was adopted for the synthesis of com-
pounds 3b–3d.
4.3.6. 6-(3,5-Dimethylpyrazol-1-yl)-2-acetylpyridine (3b)
Obtained as a yellow solid (4.33 g, 87% yield); 1H NMR (400 MHz,
CDCl3, ppm): 8.11 (d, 1H, J = 7.8 Hz, Hpyri), 7.86–7.92 (m, 2H, Hpyri),
6.03 (s, 1H, Hpyra), 2.74 (s, 3H, CH3), 2.69 (s, 3H, C(O)CH3), 2.30
(s, 3H, CH3). 13C NMR (100 MHz, CDCl3, ppm): 199.43, 152.70,
151.20, 150.37, 141.62, 139.22, 118.97, 118.27, 109.73, 26.24, 15.21,
13.65.
4a. To a methanol (25 mL) solution of 3a (748 mg, 4 mmol),
excess aniline (1.82 g, 20 mmol) and three drops of acetic acid were
added. The mixture was refluxed overnight, and all volatile was
removed under vacuum. The resulting residue was dissolved in
methanol (8.0 mL) and recrystallized at −30 ◦C to give 4a (833 mg,
80%). The same procedure was adopted for the synthesis of com-
pounds 4b–4f.
5a. A blue suspension of CoCl2 (63 mg, 2 mmol) in THF was added
to a solution of the corresponding ligand (4a, 524 mg, 2 mmol) in
10 mL of THF. The reaction mixture was stirred at room temperature
overnight, forming a brown precipitate, which was filtered, washed
with diethyl ether and hexane. Recrystallization was conducted by
slow diffusion of diethyl ether into its saturated dichloromethane
solution to give 5a (511 mg, 87%). The same procedure was adopted
for the synthesis of all cobalt complexes.
4.3.7. 6-(3,5-Diisopropylpyrazol-1-yl)-2-acetylpyridine (3c)
Obtained as a yellow oil (4.22 g, 61% yield); 1H NMR (400 MHz,
CDCl3, ppm): 8.12 (d, 1H, J = 7.6 Hz, Hpyri), 7.87 (m, 2H, Hpyri), 6.13 (s,
1H, Hpyra), 4.07 (hepta, 1H, J = 6.8 Hz, CH(CH3)2), 3.03 (hepta, 1H,
J = 6.8 Hz, CH(CH3)2), 2.67 (s, 3H, CH3), 1.30 (d, 12H, J = 6.8 Hz,
CH(CH3)2). 13C NMR (100 MHz, CDCl3, ppm): 199.45, 160.49,
153.19, 152.90, 151.31, 139.12, 120.24, 118.46, 102.78, 28.09, 26.74,
26.21, 23.06, 22.60.
4.3.8. 6-(3,5-Diphenylpyrazol-1-yl)-2-acetylpyridine (3d)
Obtained as a yellow solid (2.59 g, 55% yield); 1H NMR (400 MHz,
CDCl3, ppm): 8.21 (d, 1H, J = 7.8 Hz, Hpyri), 7.86–7.97 (m, 4H,
2HAr, 2Hpyri), 7.48–7.36 (m, 8H, HAr), 6.83 (s, 1H, Hpyra), 1.89 (s,
3H, C(O)CH3). 13C NMR (100 MHz, CDCl3, ppm): 199.41, 152.85,
151.74, 151.12, 145.48, 139.37, 132.61, 132.58, 128.89, 128.78,
128.53, 128.22, 128.10, 126.00, 120.31, 119.16, 107.73, 24.97. Anal.
Calcd. For C22H17N3O1: C, 77.86; H, 5.05; N, 12.38. Found: C, 77.50;
H, 5.29; N, 11.99.
4.3.1. 6-(Pyrazol-1-yl)-ethylpyridine-2-carboxylate (2a)
Obtained as a white solid (4.50 g, 70% yield); 1H NMR (400 MHz,
CDCl3, ppm): 8.62 (s, 1H, Hpyra), 8.14 (d, 1H, J = 7.8 Hz, Hpyri), 8.04
(d, 1H, J = 7.8 Hz, Hpyri), 7.95 (t, 1H, J = 7.8 Hz, Hpyr), 7.73 (s, 1H,
Hpyra), 6.48 (s, 1H, Hpyra), 4.49 (q, 2H, J = 8.8 Hz, CH2CH3), 1.43 (t,
3H, J = 8.8 Hz, CH2CH3). 13C NMR (100 MHz, CDCl3, ppm): 165.11,
154.99, 150.97, 151.52, 143.00, 123.77, 118.89, 113.51, 106.99,
62.00, 13.41.
4.3.9. 2-[1-(Phenylimino)ethyl]-6-(pyrazol-1-yl)-pyridine (4a)
Obtained as a yellow solid (833 mg, 80%); 1H NMR (400 MHz,
CDCl3, ppm): 8.61 (s, 1H, Hpyra), 8.16 (d, 1H, J = 7.8 Hz, Hpyri), 8.07
(d, 1H, J = 7.8 Hz, Hpyri), 7.92 (t, 1H, J = 7.8 Hz, Hpyr), 7.76 (s, 1H, Hpyra),
7.40–7.38 (m, 2H, HAr), 7.12–7.10 (m, 1H, HAr), 7.85–7.83 (m, 2H,
HAr), 6.48 (s, 1H, Hpyra). 13C NMR (100 MHz, CDCl3, ppm): 166.61,
155.21, 151.13, 150.50, 142.17, 139.21, 129.06, 127.00, 123.77,
119.24, 118.86, 113.31, 107.80, 16.28. IR (KBr, cm−1): 1637 (vC N),
Anal. Calcd. For C16H14N4: C, 73.26; H, 5.38; N, 21.36. Found: C,
74.01; H, 5.04; N, 21.69.
4.3.2. 6-(3,5-Dimethylpyrazol-1-yl)-ethylpyridine-2-carboxylate
(2b)
Obtained as a white solid (5.20 g, 85% yield); 1H NMR (400 MHz,
CDCl3, ppm): 8.09 (d, 1H, J = 7.6 Hz, Hpyri), 7.98–7.95 (m, 2H, Hpyri),
6.35 (s, 1H, Hpyra), 4.44 (q, 2H, J = 8.8 Hz, CH2CH3), 2.75 (s, 3H,
CH3), 2.25 (s, 3H, CH3), 1.41 (t, 3H, J = 8.8 Hz, CH2CH3). 13C NMR
(100 MHz, CDCl3, ppm): 165.00, 153.33, 150.40, 146.06, 142.40,
139.13, 121.59, 118.53, 109.57, 61.76, 14.84, 14.31, 13.73.
4.3.3.
6-(3,5-Diisopropylpyrazol-1-yl)-ethylpyridine-2-carboxylate (2c)
Obtained as a colorless oil (3.90 g, 54% yield); 1H NMR (400 MHz,
CDCl3, ppm): 8.07 (m, 1H, 7.8 Hz, Hpyri), 7.98–7.86 (m, 2H, Hpyri),
6.01 (s, 1H, Hpyra), 4.45 (q, 2H, J = 8.4 Hz, CH2CH3), 4.11 (hepta,
1H, J = 8.0 Hz, CH(CH3)2), 3.03 (hepta, 1H, J = 8.0 Hz, CH(CH3)2),
1.40 (t, 3H, J = 8.4 Hz, CH2CH3), 1.25 (d, 12H, CH(CH3)2). 13C NMR
(100 MHz, CDCl3, ppm): 164.55, 152.13, 151.42, 147.13, 143.41,
138.53, 120.99, 117.46, 108.31, 60.55, 26.74, 26.21, 23.06, 22.60,
12.89.
4.3.10. 2-[1-(2,4,6-Trimethylphenylimino)ethyl]-6-(pyrazol-1-
yl)-pyridine
(4b)
Obtained as a yellow solid (1.34 g, 66%); 1H NMR (400 MHz,
CDCl3, ppm): 8.62 (s, 1H, Hpyra), 8.24 (d, 1H, J = 8.0 Hz, Hpyri), 8.07 (d,
1H, J = 8.0 Hz, Hpyri), 7.96 (t, 1H, J = 8.0 Hz, Hpyri), 7.76 (s, 1H, Hpyra),
6.90 (s, 2H, HAr), 6.48 (s, 1H, Hpyra), 2.29 (s, 3H,
N CH3), 2.20 (s, 3H,
Ar CH3), 2.00 (s, 6H, Ar CH3). 13C NMR (100 MHz, CDCl3, ppm):
166.65, 154.95, 151.44, 146.23, 142.14, 139.17, 132.35, 128.59,
126.97, 125.23, 118.67, 113.27, 107.75, 20.75, 17.88, 16.45. IR (KBr,
cm−1): 1649 (vC N), Anal. Calcd. For C19H20N4: C, 74.97; H, 6.62; N,
18.41. Found: C, 74.63; H, 6.91; N, 18.40.
4.3.4. 6-(3,5-Diphenylpyrazol-1-yl)-ethylpyridine-2-carboxylate
(2d)
Obtained as a white solid (3.76 g, 83% yield).1H NMR (400 MHz,
CDCl3, ppm): 8.01 (m, 1H, 7.8 Hz, Hpyri), 7.87–7.96 (m, 4H, 2HAr
,
4.3.11. 2-[1-(2,6-Diisopropylphenylimino)ethyl]-6-(pyrazol-1-
yl)-pyridine
2Hpyri), 7.48–7.36 (m, 8H, HAr), 6.69 (s, 1H, Hpyra), 4.40 (q, 2H,
J = 8.4 Hz, CH2CH3), 1.44 (t, 3H, J = 8.4 Hz, CH2CH3). 13C NMR
(100 MHz, CDCl3, ppm): 165.43, 151.33, 151.10, 145.44, 143.44,
135.52, 133.44, 132.59, 128.99, 128.82, 128.67, 128.21, 128.17,
125.89, 121.44, 117.42, 114.51, 64.22, 11.33.
(4c)
Obtained as a yellow solid (870 mg, 69%); 1H NMR (400 MHz,
CDCl3, ppm): 8.66 (s, 1H, Hpyra), 8.26 (d, 1H, J = 8.0 Hz, Hpyri), 8.09
(d, 1H, J = 8.0 Hz, Hpyri), 7.98 (t, 1H, J = 8.0 Hz, Hpyri), 7.77 (s, 1H,
Hpyra), 7.20–7.01 (m, 3H, HAr), 6.51 (s, 1H, Hpyra), 2.75 (hepta,
4.3.5. 6-(Pyrazol-1-yl)-2-acetylpyridine (3a)
2H, J = 4.8 Hz, CH(CH3)2), 2.24 (s, 3H, CH3), 1.16 (d, 12H,
N
Obtained as a yellow solid (3.24 g, 82% yield); 1H NMR (400 MHz,
CDCl3, ppm): 8.60 (s, 1H, Hpyra), 8.16 (d, 1H, J = 7.6 Hz, Hpyri),
7.97–7.90 (m, 2H, Hpyri), 7.76 (s, 1H, Hpyra), 6.50 (s, 1H, Hpyra), 2.75
(s, 3H, CH3). 13C NMR (100 MHz, CDCl3, ppm): 199.11, 155.01,
151.09, 152.54, 143.04, 123.88, 118.71, 113.46, 106.45, 26.14.
J = 4.8 Hz, CH(CH3)2). 13C NMR (100 MHz, CDCl3, ppm): 166.28,
154.79, 150.55, 146.31, 142.28, 139.26, 135.79, 132.49, 127.03,
123.40, 123.06, 122.79, 118.72, 113.30, 107.77, 28.33, 23.22, 22.92,
17.21. IR (KBr, cm−1): 1635 (vC N), Anal. Calcd. For C22H26N4: C,
76.27; H, 7.56; N, 16.17. Found: C, 77.01; H, 7.39; N, 16.39.